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Abstract
Erythropoietin (Epo)-induced Stat5 phosphorylation (p-Stat5) is essential for both basal erythropoiesis and for its
acceleration during hypoxic stress. A key challenge lies in understanding how Stat5 signaling elicits distinct functions during
basal and stress erythropoiesis. Here we asked whether these distinct functions might be specified by the dynamic behavior
of the Stat5 signal. We used flow cytometry to analyze Stat5 phosphorylation dynamics in primary erythropoietic tissue in
vivo and in vitro, identifying two signaling modalities. In later (basophilic) erythroblasts, Epo stimulation triggers a low
intensity but decisive, binary (digital) p-Stat5 signal. In early erythroblasts the binary signal is superseded by a high-intensity
graded (analog) p-Stat5 response. We elucidated the biological functions of binary and graded Stat5 signaling using the
EpoR-HM mice, which express a ‘‘knocked-in’’ EpoR mutant lacking cytoplasmic phosphotyrosines. Strikingly, EpoR-HM mice
are restricted to the binary signaling mode, which rescues these mice from fatal perinatal anemia by promoting binary
survival decisions in erythroblasts. However, the absence of the graded p-Stat5 response in the EpoR-HM mice prevents
them from accelerating red cell production in response to stress, including a failure to upregulate the transferrin receptor,
which we show is a novel stress target. We found that Stat5 protein levels decline with erythroblast differentiation,
governing the transition from high-intensity graded signaling in early erythroblasts to low-intensity binary signaling in later
erythroblasts. Thus, using exogenous Stat5, we converted later erythroblasts into high-intensity graded signal transducers
capable of eliciting a downstream stress response. Unlike the Stat5 protein, EpoR expression in erythroblasts does not limit
the Stat5 signaling response, a non-Michaelian paradigm with therapeutic implications in myeloproliferative disease. Our
findings show how the binary and graded modalities combine to generate high-fidelity Stat5 signaling over the entire basal
and stress Epo range. They suggest that dynamic behavior may encode information during STAT signal transduction.
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Healthy individuals at sea level continuously generate red blood
cells in a process known as ‘‘basal erythropoiesis’’ that is essential
to life. Erythropoiesis increases by up to 10-fold its basal rate in
response to hypoxic stress, as may occur at high altitude, or in
response to anemia or hemorrhage. Erythropoietic rate is
regulated by the hormone Erythropoietin (Epo), whose concen-
tration in blood spans a remarkable, three orders of magnitude
range, from <0.01 U/ml in the basal state to 10 U/ml in extreme
stress. Epo exerts its effects by binding to its receptor, EpoR, a
transmembrane homodimer of the cytokine receptor superfamily
expressed by erythroid progenitors [1]. Epo or EpoR-null mice die
at mid-gestation as a result of complete absence of mature red cells
[2], and EpoR signaling is essential for both basal and stress
erythropoiesis [3–7]. Binding and activation of the EpoR results in
activation of the cytoplasmic tyrosine kinase Jak2, and in
phosphorylation of EpoR cytoplasmic-domain tyrosines that act
as docking sites for signaling intermediates including Stat5
[8].
A key challenge lies in understanding how EpoR signaling
might differ between stress and basal conditions. This challenge is
of particular relevance to clinical practice, where Epo is widely
used and where erythropoietic mimetics are under intense
development to maximize benefit while reducing risk [9,10]. Here
we addressed this question by studying Stat5, which, as suggested
by mouse genetic models, is a key mediator of both basal and stress
erythropoiesis. Thus, Stat5-null mice die perinatally due to
anemia, while mice hypomorphic for Stat5 survive, but are
deficient in their response to erythropoietic stress [6,7,11,12].
Stat5 functions are due to two highly homologous proteins,
Stat5a and Stat5b, of the Signal Transducers and Activators of
Transcription (STAT) family. STAT proteins are latent cytoplas-
mic transcription factors that become activated by phosphoryla-
tion of a C-terminal tyrosine in response to a variety of
extracellular signals [13,14]. Stat5 is a key mediator of cell
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survival in erythroblasts and other hematopoietic progenitors. In
addition, it is frequently constitutively active in myeloproliferative
disease and in hematological malignancies [6,7,11,12].
Here we asked whether the dynamic behavior of the Stat5
activation signal, namely, the way it varies with Epo concentration
and with time, differs between stress and basal erythropoiesis.
Previously, distinct dynamic forms of ERK or Ras signaling have
been shown to specify distinct cellular responses [15,16]. The
dynamic form of a signal, however, is often masked when
measured in large populations of cells whose responses are
inherently variable. Analysis of a signal’s dynamic properties
therefore requires measurement in single cells, with relatively few
such studies to date.
To address this, we analyzed Stat5 signaling using flow-
cytometry, in primary murine erythroid progenitors, either in
vivo or shortly following harvest (,24 h). We combined two
recent flow-cytometric assays, identifying differentiation-stage-
specific erythroblasts in tissue using cell-surface markers [17–19]
and measuring their Stat5 phosphorylation signal (p-Stat5) using
intracellular flow-cytometry [20]. We determined the time course
and full dose-response curves of the p-Stat5 response to the entire
basal and stress Epo concentration range, in freshly harvested fetal
liver erythroblasts at five distinct stages of differentiation.
We found that Stat5 signals through two modalities, binary
(digital) and graded (analog). We characterized these modalities
using wild-type mice and an EpoR mutant mouse that we found to
be restricted to the binary Stat5 signaling modality. We show that
later erythroblasts generate a low intensity but decisive, binary
‘‘on’’ or ‘‘off’’ p-Stat5 signal that is both necessary and sufficient
for mediating Stat5 functions in basal erythropoiesis. By contrast,
in early erythroblasts Stat5 signaling is graded, reaching much
higher signal intensities that are necessary for the stress response,
including the upregulation of the transferrin receptor (CD71), a
novel EpoR and Stat5 stress target.
The orderly transition in the modality of Stat5 signaling from
early to later erythroblasts is due to decreasing Stat5 protein levels
with erythroid maturation. Stat5 protein levels determine both
maximal p-Stat5 signal intensity and the steepness of the Stat5
signaling response. This contrasts with EpoR expression, which
does not appear to impose a limit on the maximal p-Stat5
response.
Our work shows that Stat5 signaling dynamics conveys
information specifying the required functional outcome in
erythroblasts. The unique combination of a steep, binary response
to low Epo in the basal state, with a higher intensity graded
signaling modality during stress, allows Stat5 to transduce Epo
stimuli with high fidelity over its entire physiological and stress
range.
Results
Flow Cytometric Measurement of Phosphorylated-Stat5
(p-Stat5) in Primary Erythroblasts
Murine erythropoiesis takes place in fetal liver between
embryonic days 12 (E12) and 15. To examine intracellular Stat5
activation by phosphorylation, we fixed and permeabilized fresh
fetal liver cells, which we then labeled with an AlexaFluor647-
conjugated antibody specific to the Stat5 C-terminal phosphotyr-
osine. In addition, we labeled the cells’ surface with antibodies
directed at CD71 and Ter119, which may be used to stage
erythroblast maturation [17,18,21,22]. We distinguished subsets
S0 to S4 in the fixed fetal liver, with the earliest erythroid cells in
S0, maturing into increasingly differentiated erythroblasts in S1
through S4; S3 is further subdivided into earlier, large cells and
more differentiated, small cells (Figure 1A). Unless otherwise
stated, ‘‘S3’’ below refers to ‘‘S3 large.’’ All cells in subsets S1 to S3
are Epo-dependent erythroid precursors; S0 is composed of
earlier, Epo-independent erythroid progenitors (70%) and non-
erythroid cells (30%, [18]). Following stimulation of freshly
isolated fetal liver cells with Epo, we measured an Epo-dependent
signal with the anti-phosphorylated-Stat5 (p-Stat5) antibody
(Figure 1B). This signal was specific to the active, p-Stat5, since
it was obtained in wild-type, but not in Stat52/2 fetal liver
(Figure 1B, upper panels). Further, the p-Stat5 signal was lost if,
following Epo stimulation, fixed cells were incubated with l
phosphatase (Figure 1B, lower panels). Work below also
confirmed, with the use of a Stat5 mutant, that the signal is
specific to the C-terminal Y694 residue.
Erythroid Maturation Determines the p-Stat5 Response
We stimulated freshly isolated fetal liver cells with Epo and
examined the resulting p-Stat5 response in each of the fetal liver
subsets (Figure S1A; Figure 1C–E). We measured three aspects of
the p-Stat5 fluorescence signal (Figure 1C). First, ‘‘total p-Stat5’’
corresponds to the p-Stat5 median fluorescence intensity (MFI) of
the entire subset population; the total p-Stat5 MFI of all S3 subset
cells in the red histogram, upper panel of Figure 1C, is 1,200
fluorescence units. This measure includes both signaling and non-
signaling cells. Second, we measured the fraction of cells that are
‘‘p-Stat5 positive’’ (p-Stat5+), lying within the p-Stat5+ gate
(Figure 1C, lower panel), as an estimate of the fraction of signaling
cells. The placement of the p-Stat5+ gate was determined by
reference to the baseline, pre-stimulation histogram (black
histogram, Figure 1C, lower panel), which was closely similar to
that of cells stained with an isotype-control antibody in place of the
anti-p-Stat5 antibody. Last, we measured the ‘‘p-Stat5 in p-Stat5+
Author Summary
Hormone signaling through the erythropoietin (Epo)
pathway is required both for the continuous replacement
of red blood cells (RBCs) that are lost through aging (a
process known as ‘‘basal erythropoiesis’’) and to boost
tissue oxygen when bleeding, in anemia or at high altitude
(‘‘stress erythropoiesis’’). A key challenge lies in under-
standing how extracellular Epo concentration is translated
into different intracellular signals that promote transcrip-
tion of proteins that are specific to basal versus stress
erythropoiesis. Binding of Epo to its receptor EpoR on the
surface of an erythroblast (the precursors of RBCs) triggers
the addition of phosphates to a target protein Stat5; the
phosphorylated Stat5 becomes activated and induces
transcription. We show that the dynamic properties of
the Stat5 activation signal convey additional information
that specifies either basal or stress responses. During basal
conditions, the Stat5 signal is low and binary in nature—an
on/off switch-like response. Stress, on the other hand,
triggers a distinct Stat5 response consisting of a high-
intensity signal that increases in a graded fashion with
rising Epo concentration. We found that a mouse bearing a
truncated EpoR is restricted to the low-intensity binary
Stat5 signal and correspondingly fails to initiate stress
erythropoiesis. Ultimately, it is the Stat5 protein level in
erythroblasts that determines their ability to generate the
high-intensity graded Stat5 signal in response to high Epo.
These findings have therapeutic potential: targeting Stat5’s
high-intensity graded signal may inhibit its aberrant
function in blood cell cancers without affecting its
important binary response in normal cells.
Stat5 Signals through Binary and Graded Modalities
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cells,’’ which estimates the p-Stat5 MFI in signaling cells only
(Figure 1C, lower panel, where p-Stat5 in p-Stat5+ cells is 1,700
fluorescence units).
Using these measures, we examined the p-Stat5 response to Epo
at 15 min post-stimulation, when a peak response is attained (see
time course of activation, Figure S1B). The p-Stat5 signal intensity
was highest in S1, decreasing with erythroid maturation through
subsets S2 and S3 (Figure S1A). In the earliest, S0 subset, only
,25% of cells responded to Epo, suggesting that the p-Stat5
response pathway becomes fully activated only with the onset of
Epo dependence at the transition from S0 to S1, when a number
of key transcriptional and epigenetic changes take place in
erythroid progenitors (Figure S1A,C [18,19]).
We contrasted the response of S1 and S3 cells to a range of Epo
concentrations encountered in physiological (,0.05 U/ml) and
hypoxic-stress conditions (0.05 to 10 U/ml; Figure 1D; each
histogram in the left panels is represented as a data-point of the
same color in the dose/response curves in the right panels). S1
cells generated a graded increase in total p-Stat5 in response to
increasing Epo (Figure 1D, right upper panel), which reflected a
graded increase in both the number of signaling cells (p-Stat5+
cells, Figure 1D, right middle panel) and in the signal intensity of
signaling cells (Figure 1D, lower right panel). ‘‘S3 large’’ ( = ‘‘S3’’)
cells attained a <4-fold lower signal than S1 cells. The S3 cell
population also showed a graded increase in total p-Stat5 with
increasing Epo stimulation (Figure 1D, right upper panel).
However, this was principally the result of an increase in the
number of signaling cells with Epo concentrations (Figure 1D,
right middle panel); the p-Stat5 signal intensity within signaling
cells remained relatively constant (Figure 1D, right lower panel). A
summary of five independent experiments for all erythroid subsets
shows that these dose/response characteristics are reproducible
(Figure 1E).
Graded versus Binary Signaling in Cell Populations
In spite of wide variation in the number of responding cells, the
p-Stat5 signal intensity of S3 cells with a positive p-Stat5 response
(p-Stat5 MFI in p-Stat5+ cells) remained relatively constant
(Figure 1E, middle and lower panels). We found that matura-
tion-stage equivalent cells in adult tissue behaved similarly
(‘‘EryA’’ erythroblasts, Figure S2). Together, these findings raised
the possibility that S3 cells may be generating a binary p-Stat5
response. Under this hypothesis, p-Stat5 activation in individual
S3 cells would be switch-like, with cells either expressing their
maximal p-Stat5 levels regardless of Epo concentration (and are
‘‘on’’) or failing to respond and remaining ‘‘off.’’ In an idealized
switch-like response, an infinitesimally small increase in stimulus in
the region of the stimulus threshold can cause the response to
increase from 0% to 100%. The Hill coefficient of this idealized
step-like dose/response curve approaches infinity (Figure 2A, gray
step response). Switch-like responses in biology, however, are only
approximations of this idealized case, in that the switch in response
from 0% to 100% requires a small but finite increase in the
stimulus. Goldbeter and Koshland called switch-like biological
responses ‘‘ultrasensitive’’ and defined them as steeper than the
graded hyperbolic Michaelis-Menten curve—that is, responses
with a Hill coefficient (nH) larger than 1 [23]. In a graded response
(nH=1), the stimulus needs to increase 81-fold in order to increase
the response form 10% to 90% of maximum. By contrast, in a
more switch-like, steeper response, with nH= 3, only a 4-fold
increase in stimulus is required for a similar change in response
(Figure 2A). Examples of effective switch-like responses include the
cooperative binding of oxygen to hemoglobin (nH= 2.7) and the
MAPK pathway in Xenopus oocytes (nH= 4 or 5) [24,25].
A binary p-Stat5 response in single cells may sometimes appear
to be graded when the signal is measured in a population of cells.
This is illustrated in Figure 2B, which contrasts three hypothetical
cases of signaling cells. In the first case (Figure 2B, left panels),
there is a graded increase in signal within individual cells in
response to increasing Epo concentration, resulting in a graded
increase in the total p-Stat5 MFI at the population level. The
corresponding Epo dose/p-Stat5 response curve has a Hill
coefficient of 1 (Figure 2B, left lower panel). The two hypothetical
cases of binary signaling (Figure 2B, middle and right panels) differ
from each other only in the Epo threshold at which cells respond
with a p-Stat5 signal. In the ‘‘variable threshold’’ example,
individual cells vary substantially with respect to the Epo
concentration at which they switch from ‘‘off’’ to ‘‘on.’’ The
measured p-Stat5 signal, which is the sum of the signals generated
by a large population of cells, increases in a graded manner with
increasing Epo concentration (nH= 1) (Figure 2B, lower middle
panel). The flow-cytometry histograms for each Epo dose (in color)
Figure 1. The p-Stat5 response in fetal liver. (A) Flow cytometric Ter119/CD71 profile of freshly isolated fetal liver at E13.5, fixed and
permeabilized in preparation for intracellular p-Stat5 measurements. Subsets S0 to S4 (left histogram) contain erythroblasts of increasing maturation,
as seen from their morphological appearance in cytospin preparations (stained with Giemsa and diaminobenzidine). The right histogram shows the
further division of S3 cells into small and large subsets based on the flow-cytometric ‘‘forward scatter’’ parameter. (B) Specificity of the Alexa 647-
conjugated anti-p-Stat5 antibody (BD Biosciences # 612599). Upper panels, response of S1 cells from either wild-type or Stat52/2 fetal livers to Epo
stimulation (2 U/ml) for 15 min (red histograms). Blue histograms are baseline fluorescence in the absence of Epo. Lower panels, Epo-stimulated (2 U/
ml; 15 min, red histograms) or unstimulated (blue histograms) S1 cells in wild-type fetal liver, either treated or untreated with l-phosphatase prior to
p-Stat5 staining. Numbers in all panels indicate the fraction (%) of p-Stat5 positive cells within the indicated horizontal gates. (C) The three measures
used to analyze the p-Stat5 response to Epo (9 U/ml, 15 min, red histogram) in S3 erythroblasts. The black histogram corresponds to pre-stimulation
cells of the same subset. (i) ‘‘total p-Stat5 median fluorescence intensity (MFI)’’ (upper panel), the p-Stat5 MFI of the entire S3-subset population,
represented by the shaded red histogram. This measure does not distinguish between signaling and nonsignaling cells. (ii) ‘‘p-Stat5+ cells(%)’’ (lower
panel), cells within the p-Stat5+ gate, shaded in red, expressed as a fraction (percent) of all cells in the Epo-stimulated S3 subset. This is an estimate of
the number of signaling cells. The placement of the p-Stat5+ gate was determined by reference to the baseline, pre-stimulation histogram (in black),
so that no more than 1% of the unstimulated population is included within the p-Stat5+ gate. (iii) ‘‘p-Stat5 in p-Stat5+ cells’’ (lower panel), estimates
the p-Stat5 MFI in signaling cells only. (D) Response of S1 and S3 erythroblasts to Epo stimulation. Freshly isolated fetal liver cells were deprived of
Epo for 90 min and were then stimulated with a range of Epo concentrations as indicated, from 0.004 to 9 U/ml, for 15 min. Colored flow-cytometry
histograms correspond to Epo-stimulated cells, black histograms in each panel correspond to unstimulated cells (Epo= 0). An overlay of the
responses is shown in the two lowest panels. For each Epo concentration, three measures of the p-Stat5 response, as illustrated in (C), are noted next
to each flow-cytometry histogram in blue, black, and green, corresponding to the total p-Stat5 MFI, to the p-Stat5+ cells (%), and to the p-Stat5 in p-
Stat5+ cells, respectively. Each of these measures is then plotted as a function of Epo concentration (right panels); the color of each symbol in these
plots corresponds to the color of the respective flow-cytometry histogram for the same Epo concentration. (E) The p-Stat5 response to a range of Epo
concentrations at 15 min post-stimulation. Summary of five independent experiments similar to Panel D. Data (mean6 SE) for each experiment were
normalized by expressing each p-Stat5 MFI reading as a ratio to the p-Stat5 MFI in p-Stat5+ cells of the ‘‘S3 large’’ subset following stimulation with
1 U/ml Epo for 15 min. Data in the upper two panels were fitted with Hill curves.
doi:10.1371/journal.pbio.1001383.g001
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Figure 2. Measurement of binary and graded signaling responses by flow cytometry. (A) Dose/response curves for graded and binary
(switch-like) responses. The grey line shows an idealized switch response. An infinitesimally small change in stimulus such as Epo results in an
increase of response from 0% to 100%. The black curve shows a graded response with nH = 1. An 81-fold increase in stimulus is required to shift the
Stat5 Signals through Binary and Graded Modalities
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are a composite of two underlying histograms, of non-signaling
cells (in grey) and signaling cells (in black). Only the amplitudes of
the black and grey histograms change with Epo concentration,
while their MFI remains constant. However, the MFI of the
composite, color histogram increases in a graded manner with Epo
dose. By contrast, in the second binary signaling example
(Figure 2B, right panels), cells have a similar threshold to Epo
stimulation, so that the entire cell population switches from ‘‘off’’
to ‘‘on’’ within a narrow Epo concentration range. This results in
the population response resembling the binary responses of
individual cells, with a much steeper Epo dose/p-Stat5 response
curve that is characterized by a high Hill coefficient (nH.1)
(Figure 2B, lower right panel).
A graded p-Stat5 response in the S3 population (Figure 1E, top
panel) does not therefore preclude the possibility that individual S3
cells have binary responses that are masked by a variable threshold
to Epo (as in Figure 2B, middle panel).
A Binary Low-Intensity p-Stat5 Signal in EpoR-HM
Erythroblasts
We studied p-Stat5 signaling in the EpoR-H and EpoR-HM
mouse strains, in which the respective EpoR truncation mutants
are ‘‘knocked-in’’ at the wild-type EpoR locus, replacing wild-type
EpoR (Figure 3A, [3]). EpoR-H lacks seven of the eight
cytoplasmic domain tyrosines. EpoR-HM is similarly truncated
but in addition contains the Y343F mutation and therefore lacks
tyrosine docking sites for Stat5.
S1 cells from EpoR-H fetal livers generated a p-Stat5 signal
equivalent to that of wild-type cells, but had a high p-Stat5
background in the absence of Epo stimulation, consistent with a
previously identified negative regulatory function for the EpoR
carboxy-terminal domain (Figure 3B, lower panel; [26]). S1 cells
from EpoR-HM fetal liver, by contrast, generated only a low-
intensity p-Stat5 response to Epo, consistent with previous studies
(Figure 3B, upper panel; [27]). A full Epo dose/p-Stat5 response
analysis revealed that the maximal p-Stat5 signal generated by S1
cells in EpoR-HM was <3–4-fold lower than in wild-type S1,
resembling in intensity p-Stat5 signals generated by more mature,
wild-type S3 cells (Figure 3C–D, Figure S3A). Strikingly, in
addition to their lower p-Stat5 intensity, the EpoR-HM S1
response was binary (Figure 3C–E), resembling the hypothetical
example of binary signaling in a population of cells with similar
Epo thresholds (Figure 2B, right panels). Thus, unlike wild-type
S1, the p-Stat5 fluorescence histograms in EpoR-HM S1 are in
one of two clusters, either ‘‘off’’ or ‘‘on’’ (Figure 3C, lower panel).
The switch from ‘‘off’’ to ‘‘on’’ occurs at ,0.3 U/ml (see apparent
Km values for the EpoR-HM dose/response curve, Figure S3B).
This binary behavior was reflected in the steep Epo dose/p-Sta5
response curve for EpoR-HM S1 cells (Figure 3D). In each of three
independent experiments, the Hill coefficients found for each of
the EpoR-HM fetal liver subsets were consistently higher than in
wild-type littermate controls (Figure 3E), with nH for S1 cells
ranging between 2 and 3.5. Taken together, S1 cells in EpoR-HM
have lost the high-intensity graded signaling mode characteristic of
this subset. The residual signal is of low intensity, similar to that of
S3 cells, and is binary in nature.
Binary Signaling in S3 Cells of Similar Maturation
Stage
The S3 subset consists of a spectrum of erythroblast matura-
tional stages with varying size and hemoglobin expression
(Figure 1A; [18]). Since variability between cells may mask binary
signaling properties, we attempted to subdivide S3 cells into more
uniform subsets. Maturation is associated with a decrease in cell
size. We made use of this trend to digitally sub-divide the S3
population of cells in an E14.5 fetal liver into a series of smaller
subsets, based on their forward scatter (FSC) parameter, which is a
function of cell size (Figure 3F). We confirmed that increasingly
smaller cells were indeed increasingly mature by comparing
Ter119 expression in each of the FSC gates. As expected, larger
cells in FSC gate #6 expressed less Ter119 than smaller cells in
FSC gate #3 (Figure 3F). We proceeded to analyze the Epo dose/
p-Stat5 response properties of cells in individual FSC gates, and
found that signaling by smaller and more mature cells was binary,
with high Hill coefficients; the steepness of the dose/response
curve decreased progressively in less mature cells, while the p-
Stat5 intensity increased. For comparison, the dose/response
curve for the S1 subset was much less steep (nH=1.8), similar to
that found for the least mature cells within S3 (Figure 3G).
This analysis suggests that the most mature cells within S3
generate the lowest p-Stat5 signal intensity, and have the steepest
dose/response curves, giving rise to an overall binary response
pattern. We carried out a similar analysis on S3 cells from a
younger, E12.5 embryo, in which the most mature cells within S3
had not yet developed (Figure S4). There were fewer cells in the
low FSC gates of the E12.5 embryo, and these were less mature
than in corresponding gates of the E14.5 embryos, as indicated by
Ter119 expression (Figure S4A, right panels). All dose/response
curves in the E12.5 embryos had lower Hill coefficients (nH,1.2 to
1.8) and hence a more graded response (Figure S4B). Of interest,
response from 10% to 90% of maximum. The green curve shows a steep, switch-like or binary dose/response curve (nH = 3). Only a 4-fold change in
stimulus is required in order to generate a similar increase in response. (B) Contrasting graded and binary signaling responses: three hypothetical
examples. In a graded signaling response (left panels), increasing Epo concentration results in a graded increase in p-Stat5 in individual cells,
represented by increasingly darker shades of grey. Simulations of the corresponding flow-cytometric profiles show that increasing Epo concentration
causes a gradual shift of the p-Stat5 fluorescence histogram to the right. A plot of the total p-Stat5 median fluorescence intensity (MFI) versus Epo
concentration has Michaelian kinetics with a Hill coefficient (nH) of 1 (lower left panel, please note a log scale was used for the x-axis). In binary
signaling (middle and right panels), the p-Stat5 signal in individual cells can only assume two states, either ‘‘off’’ (white) or ‘‘on’’ (black), but
intermediate states (shades of grey) are unstable. Two distinct cases of binary signaling are illustrated that differ in their threshold responses. In
‘‘variable threshold’’ (middle panels), the threshold at which Epo causes a cell to switch from ‘‘off’’ to ‘‘on’’ varies substantially between cells of the
population. Consequently, increasing Epo concentration causes a gradual increase in the number of cells that are p-Stat5+ (‘‘on’’). The simulated flow-
cytometric histograms at each Epo concentration (in color) are each the sum of two histograms, corresponding to cells that are ‘‘off’’ (light grey
histograms) and cells that are ‘‘on’’ (black histograms). The median fluorescence of the ‘‘on’’ and ‘‘off’’ histograms each remain unaffected by Epo
concentration, but as Epo increases, the number of cells in the ‘‘on’’ histogram, reflected by its height, increases, with a corresponding decrease in the
height of the ‘‘off’’ histogram. Although individual cells have binary responses, there is a graded increase in the MFI of the colored histograms
representing the whole population. Therefore, a plot of total p-Stat5 MFI versus Epo concentration shows a graded response (here, the Hill coefficient
is nH = 1). In the case of cells with binary responses and similar threshold (right panels), cells switch from ‘‘off’’ to ‘‘on’’ within a much narrower Epo
concentration range. Consequently, the response of the whole population reflects the response of individual cells more closely. Flow-cytometric
histograms representing the population tend to be in one of two principal positions, corresponding to the ‘‘on’’ or to the ‘‘off’’ states. A plot of total
p-Stat5 MFI versus Epo concentration is steep, reflected by a high Hill coefficient (nH.1).
doi:10.1371/journal.pbio.1001383.g002
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Figure 3. Binary p-Stat5 signaling in EpoR-HM mice and in mature wild-type S3. (A) Representation of the cytoplasmic domains of wild-
type EpoR or its truncated mutants, EpoR-H and EpoR-HM. Tyrosine residues are represented by red lines. Tyrosine 343 is the only remaining tyrosine
in EpoR-H, and is mutated in EpoR-HM. (B) The p-Stat5 response to Epo (2 U/ml, 30 min) in S1 cells from wild-type (WT), EpoR-H (H), or EpoR-HM (HM)
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cells in FSC gate #3 in the E12.5 fetal liver generated a similar p-
Stat5max signal intensity to that of cells in FSC gate #4 of the
E14.5 fetal liver. However, the steepness of the dose/response
curve of the two cell types was markedly different (nH= 1.6 and 5,
respectively) (Figure S4C), in line with their differing maturational
state. This analysis suggests that, for a given maximal p-Stat5
signal intensity, more mature cells generate a steeper dose/
response curve.
SOCS3 Expression Increases with Erythroblast
Maturation, Modulating the p-Stat5 Response
We investigated factors that might account for the gradual
decrease in the p-Stat5 response as cells mature (Figure 1E).
Differentiation of S1 into ‘‘S3 small’’ cells takes 24 to 48 h and
entails large changes in gene expression [18]. We examined the
potential role of two established Jak2 and Stat5 negative
regulators, Shp1 (Figure S5) and SOCS3 (Figure S6) [28]. Shp1
mRNA expression decreases with maturation from S0 to S3
(Figure S5A). There was no significant difference in either the time
course of the p-Stat5 response to Epo or in the dose/response
curve, between Shp12/2 (C57BL/6J-Ptpn6me/J) fetal liver and
littermate controls (Figure S5B–C). In contrast to Shp1, SOCS3
mRNA expression increased with the transition from S1 to S3
(Figure S6A). Knock-down of SOCS3 expression successfully
prevented its induction following Epo stimulation (Figure S6B). In
S1 cells, SOCS3 knock-down had no effect on the initial p-Stat5
response, but it prevented the decline in p-Stat5 that was
invariably detected by 2 h post-stimulation (Figure S6C, left
panels). This pattern is consistent with the known negative
feedback role of SOCS3 in Stat5 signaling [29,30]. In contrast
to S1, knock-down of SOCS3 in S3 cells increased the peak p-
Stat5 signal intensity at 15 min, suggesting that the lower p-Stat5
signal intensity in S3 is in part the result of their higher SOCS3
expression (Figure S6C, right panels).
A Decrease in Stat5 Protein Levels with Erythroid
Maturation Closely Correlates with a Decreasing p-Stat5
Response
We examined the potential role of changes in EpoR or Stat5
protein levels during erythroblast maturation. To this end we
investigated embryos heterozygous for the null allele of either
Stat5 or EpoR (Figure 4). An Epo dose/p-Stat5 response analysis
in fetal liver cells from Stat5+/2 embryos showed a clear decrease
in the p-Stat5 signal across the entire Epo concentration range in
all fetal liver subsets S1 to S3, compared with wild-type controls
(see representative example in Figure 4A; a dataset of 7 Stat5+/2
and 6 wild-type littermates embryos is summarized in Figure 4B).
Fitting Hill curves to the dose/response data yielded three
parameters: the apparent Km, the maximal p-Stat5 signal at high
Epo concentrations, defined as ‘‘p-Stat5max,’’ and the Hill
coefficient, nH (Figure S7A). In addition to the clear decrease in
p-Stat5max in all subsets of the Stat5
+/2 fetal liver (Figure 4A,B,
Figure S7A), the p-Stat5 response curve was steeper, reflected in a
higher Hill coefficient (Figures 4B and S7A). There was also a shift
to the right (increase in the apparent Km) in Stat5
+/2 S3 cells. The
apparent Km reflects a number of separate sequential interactions:
binding of Epo to the EpoR, Jak2 activation, Jak2 phosphorylation
of the EpoR, binding of Stat5 to the phosphorylated EpoR, and
phosphorylation of Stat5. A change in the apparent Km can in
principle be due to alterations anywhere in this pathway. Reduced
expression of Stat5 in Stat5+/2 embryos may affect recruitment of
Stat5 to EpoR phosphotyrosines, potentially explaining the higher
apparent Km.
To assess the relation between Stat5 protein levels and the
maximal p-Stat5 response more precisely, we measured Stat5
protein levels in individual cells within each of the Stat5+/2 and wild-
type embryos, using anti-Stat5 antibodies and flow cytometry, a
method that we verified using the Stat5-null fetal livers (Figure S7D).
Stat5 protein levels in wild-type fetal liver decreased with
maturation, being highest in S1 and 4-fold lower in ‘‘S3 large’’ cells
(Figure 4D,E, closed symbols). A similar pattern was observed in
Stat5+/2 embryos, but for each corresponding subset, Stat5 protein
levels were approximately halved compared with wild-type cells
(Figure 4D,E, open symbols). There was a linear correlation
(R2= 0.85) between Stat5 protein levels in each of the wild-type or
Stat5+/2 fetal liver subsets and their corresponding maximal p-Stat5
response (p-Stat5max, Figure 4F; p-Stat5max was determined by
fitting a Hill curve to data from each embryo). These findings suggest
that decreased Stat5 protein levels may cause the decrease in the p-
Stat5 response with cell maturation in wild-type embryos (Figure 1E),
as well as the reduced p-Stat5max in Stat5
+/2 embryos (Figure 4A,B).
The p-Stat5 Response in the EpoR+/2 Fetal Liver
We examined the Epo dose/p-Stat5 response in fetal livers
derived from EpoR+/2 embryos and their littermate controls
(Figure 4C). EpoR+/2 fetal livers had an approximately 2-fold
decrease in EpoR mRNA (Figure S7B). Unlike the Stat5+/2
embryos, there was no change in p-Stat5max in EpoR
+/2 fetal liver.
Instead, the EpoR+/2 dose/response curves were shifted to the
right, with a 2-fold increase in the apparent Km (Figure 4C, Figure
S7C), raising the possibility that a doubling in Epo concentration
compensated for the reduced expression of EpoR. Therefore,
although EpoR+/2 fetal liver requires a higher Epo concentration to
elicit a given p-Stat5 signal, the likely reduced cell-surface EpoR in
these embryos appears not to limit the maximal p-Stat5 response.
To investigate this further, we asked whether EpoR+/2 fetal
livers in fact have less EpoR available for activation. We sorted
Ter119 negative cells, equivalent to subsets S0 and S1, from E13.5
fetal livers on E13.5. Percentage of cells in the p-Stat5+ gate is indicated. (C) Fluorescence p-Stat5 histogram overlay of S1 cells from E13.5 wild-type
(top) or EpoR-HM (bottom), stimulated with a range of Epo concentrations for 30 min. Representative of three similar experiments. S1 cells in each
case are pooled from several fetal livers of the same genotype. (D) Epo dose/p-Stat5 response curves, in wild-type or EpoR-HM S1 cells; the p-Stat5
MFI data correspond to the histograms shown in (C). Data are fitted with Hill curves. The Hill curves that were fitted to the data in the top panel were
re-plotted in the bottom panel and are shown as a fraction of the maximal p-Stat5 response (p-Stat5max). The p-Stat5max was calculated from fitting
the Hill equation to the experimental ‘‘total p-Stat5’’ data. Hill coefficients (nH) are indicated. (E) Lower panel, table summarizing the Hill coefficients
(nH) obtained by fitting the Hill curve to plots of ‘‘total p-Stat5 versus Epo concentration,’’ for each of subsets S1 to S3, in each of three independent
experiments. Fetal liver cells were pooled from three or four embryos of each genotype in each experiment. Differences between nH for EpoR-HM and
WT are significant at p= 0.01, paired t test. R2 is Pearson’s product moment correlation coefficient, correlating experimental data with values
predicted by the Hill equation for the corresponding Epo concentrations. (F) CD71/Ter119 profile of E14.5 fetal livers (left panel). The S3 subset was
further divided into serial FSC gates, each corresponding to 300 channels (middle panel). The right panel shows an overlay of Ter119 expression in
FSC gates #3 and #6. (G) Epo dose/p-Stat5 response curves for the S3 FSC gates #3–6 and for S1 cells in the same fetal liver. Gate number and
corresponding Hill coefficient are shown for each curve.
doi:10.1371/journal.pbio.1001383.g003
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fetal livers of either wild-type or EpoR+/2 embryos. We briefly
stimulated the cells with a high Epo concentration that would be
expected to generate a maximal p-Stat5 response (2 U/ml for
5 min). We used quantitative Western blot analysis to examine
both p-Stat5 and phosphorylated EpoR (p-EpoR) in each fetal
liver (Figure S8). This analysis showed that EpoR+/2 fetal liver
cells had reduced p-EpoR but not reduced p-Stat5; specifically, the
ratio of p-EpoR to p-Stat5 in each fetal liver was significantly
higher in wild-type compared with the EpoR+/2 embryos
(1.760.02 versus 1.160.08, p=0.002; Figure S8B). These results
support the conclusion that EpoR expression in primary fetal liver
cells is present at sufficiently high levels so as not to limit the
maximal p-Stat5 signal.
Exogenous Stat5 Protein Endows EpoR-HM and Wild-
Type S3 with a Graded, High-Intensity p-Stat5 Response
To test whether the loss of the high-intensity p-Stat5 response in
mature, S3 cells is indeed due to their decreased Stat5 expression
(Figure 4D–F), we asked whether we could rescue high-intensity
Stat5 signaling in these cells by exogenously expressing Stat5. In
parallel, we also examined the effect of exogenous Stat5 expression
in EpoR-HM erythroblasts, which signal exclusively via the low-
intensity binary signaling mode (Figure 3C–E). We electroporated
FLAG-tagged Stat5a constructs (‘‘FLAG-Stat5’’), or two control
constructs, either FLAG-tagged Stat5aY694F (‘‘FLAG-Sta-
t5Y694F’’) lacking the C-terminal tyrosine, or ‘‘empty vector’’
(‘‘pcDNA3’’), into freshly isolated wild-type or EpoR-HM fetal
Figure 4. Maximal p-Stat5 signal intensity (p-Stat5max) is linearly correlated with Stat5 protein levels. (A) The p-Stat5 response of S1
cells from Stat5+/2 fetal liver and from littermate wild-type controls. Representative p-Stat5 fluorescence histograms are shown for the indicated Epo
concentrations. (B) Plots of ‘‘total p-Stat5 versus Epo concentration’’ in Stat5+/2 and in wild-type littermate fetal livers in experiments similar to (A),
fitted with Hill curves. Data (mean6 SE) from n= 7 Stat5+/2 embryos and 6 littermate controls, each analyzed separately. p-Stat5 MFI was normalized
as in Figure 1E. Parameter values used for fitting the Hill curves and goodness of fit information are in Figure S7A. (C) Plots of ‘‘total p-Stat5 versus Epo
concentration’’ in EpoR+/2 and in wild-type littermate fetal livers, fitted with Hill curves. Data (mean 6 SE) from n= 4 EpoR+/2 embryos and 3
littermate controls, each analyzed separately. p-Stat5 MFI was normalized as in Figure 1E. Parameter values used for fitting the Hill curves and
goodness of fit information are in Figure S7C. (D) Stat5 protein levels in S1 to S3, in representative wild-type (WT) and Stat5+/2 embryos, using flow-
cytometric measurements with an anti-Stat5 antibody, characterized in Figure S7D using Stat52/2 embryos. FMO, ‘‘fluorescence minus one’’ control,
in which cells were labeled for all parameters (Ter119, CD71, live/dead stain) except one: the anti-Stat5 antibody was omitted and replaced with an
isotype-control antibody. (E) Stat5 protein levels in subsets S1 to S3 in wild-type or Stat5+/2 embryos. Individual data points correspond to data from
individual embryos, measured as in panel D. Stat5 protein is expressed as a ratio to the average fluorescence signal for S1 cells in all wild-type
embryos. (F) Linear correlation between Stat5 protein levels and p-Stat5max, across all subsets in Stat5
+/2 and wild-type embryos (R2 = 0.85). Data
points correspond to individual embryos. Stat5 protein levels are as in (D). p-Stat5max was determined by fitting Hill curves to individual embryo ‘‘total
p-Stat5 versus Epo concentration’’ analyses, with p-Stat5 normalized as in Figure 1E.
doi:10.1371/journal.pbio.1001383.g004
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liver. Cells were incubated overnight in the presence of Epo
(0.2 U/ml) to allow expression of the transduced constructs and
were then deprived of Epo for 3 h prior to stimulation with a
range of Epo concentrations (0.004 to 9 U/ml) for 15 min. Cells
were immediately fixed and labeled with both anti-FLAG and
anti-p-Stat5 antibodies. A single electroporation contained cells
with a spectrum of FLAG expression levels, allowing us to
determine how FLAG-Stat5 expression affected the p-Stat5
response (Figure 5).
We first examined how exogenous FLAG-Stat5 protein levels
compared with endogenous Stat5 (Figure S9). Freshly isolated S3
cells express lower levels of the Stat5 protein than S1 cells
(Figure 4D,E, Figure S9A, top panel). Following transfection with
FLAG-Stat5, Stat5 protein in S3 cells increased to levels similar to
those of the endogenous protein in S1 cells (Figure S9A, lower
panel). We were therefore in a position to ask whether increasing
Stat5 protein in S3 would be sufficient for these cells to generate
the high-intensity p-Stat5 signal characteristic of S1. A minority of
transfected S3 (18%, Figure S9A) expressed FLAG-Stat5 at higher
levels than endogenous Stat5 in fresh S1. Of these, approximately
2% retained p-Stat5 following 3 h Epo deprivation (Figure 5A,
double-headed arrow). We excluded all cells expressing the very
high FLAG-Stat5 levels from further analysis, by gating specifically
on cells with lower FLAG fluorescence. This was possible as FLAG
fluorescence was an accurate measure of the level of the exogenous
FLAG-Stat5 protein (Figure S9B).
For a given Epo concentration, the p-Stat5 response of
transfected S3 cells increased with increasing FLAG-Stat5 levels
(Figure 5A, top middle panel). There was no increase in the p-
Stat5 signal in cells transfected with FLAG-Stat5Y694F, verifying
that the p-Stat5 signal detected with increasing FLAG-Stat5 is
indeed specific (Figure 5A, central panel). To analyze the p-Stat5
response quantitatively for each FLAG-Stat5 expression level, we
sub-divided the ‘‘p-Stat5 versus FLAG-Stat5’’ dot histograms into
narrow vertical gates, each containing cells with similar levels of
FLAG-Stat5 (Figure 5B, left panels). Three of these vertical gates,
numbered 10 to 12, are color coded in red, green and blue
respectively. Cells in these gates are shown either unstimulated
(Figure 5B, top left panel) or stimulated with Epo concentrations of
0.33 U/ml (middle left panel) or 9 U/ml (Figure 5B, lower left
panel). Panels to the right show an overlay of the cells’ responses in
each of the red, green, or blue vertical gates (Figure 5B).
The entire dataset of the p-Stat5 response to nine Epo
concentrations in each of four vertical gates (9 to 12) for either
wild-type or EpoR-HM S3 cells were fitted with Hill curves
(Figure 5C). These show that exogenous FLAG-Stat5 has two
principal effects. First, the maximal response (p-Stat5max) in any
given vertical gate is positively and linearly correlated with the
level of FLAG-Stat5 protein in that gate (Figure 5D). Second, as
FLAG-Stat5 levels increase, there is a decrease in the steepness of
the p-Stat5 response curve, reflected by a decreasing Hill
coefficient (Figure 5C). As examples, transfected EpoR-HM S3
cells containing high FLAG-Stat5 levels had a dose/response
curve with a lower Hill coefficient and a higher p-Stat5max
(nH= 1.0, p-Stat5max = 1,100, gate 12, FLAG MFI= 1,700) than
cells in the same sample containing lower levels of FLAG-Stat5
(nH= 4.0, p-Stat5max = 120, gate 9, FLAG MFI= 340). Similarly,
wild-type S3 cells containing very low levels of FLAG-Stat5 had a
dose/response curve with a higher Hill coefficient and lower p-
Stat5max (nH=3.5, p-Stat5max = 25, gate 6, FLAG MFI= 75) than
cells in the same sample with higher FLAG-Stat5 (nH= 1.0, p-
Stat5max = 100, gate 8, FLAG MFI= 200).
Therefore, by varying the level of the Stat5 protein in mature S3
erythroblasts from either wild-type or EpoR-HM fetal livers, we
were able to generate the entire spectrum of Stat5 signaling
responses encountered in the erythroblast maturation series
(Figure 1E). Taken together, the data in Figures 4 and 5 show
that decreasing Stat5 protein levels with erythroblast maturation is
the cause of the gradual shift from high-intensity, graded signaling
in early erythroblasts to low-intensity, binary signaling in mature
erythroblasts.
The loss of high-intensity Stat5 signaling in EpoR-HM shows
that, in addition to high levels of the Stat5 protein, this mode of
signaling also requires Stat5 phosphotyrosine docking sites on the
EpoR. Exogenous expression of Stat5 successfully compensated for
the EpoR-HM mutation, rescuing high-intensity graded signaling
in these cells (Figure 5).
The linear dependence of p-Stat5max on Stat5 protein levels,
whether endogenous (Figure 4F) or exogenous (Figure 5D),
indicates that Stat5 is limiting for Stat5 phosphorylation in
erythroid cells. By contrast, EpoR expression in erythroblasts is not
limiting to the maximal p-Stat5 response (Figure 4C). The
Michaelis-Menten model of enzyme kinetics assumes that the
substrate is present in excess. It therefore is unlikely to apply to the
behavior of Stat5 activation in erythroblasts [31,32]. The kinetics
that apply instead is further analyzed in Text S1.
Binary Low-Intensity Stat5 Signaling Rescues Mice from
Fatal Perinatal Anemia
We used Stat52/2 and EpoR-HM mice to elucidate the specific
biological functions of the binary and graded Stat5 signaling
modalities. Mice lacking Stat5 die perinatally of severe anemia
[6,12,33,34], suggesting that the functions of Stat5 in erythropoi-
esis are essential to life. By contrast, EpoR-HM mice, which retain
only the binary low-intensity p-Stat5 signal, are viable and have
near-normal basal erythropoiesis. Therefore, the low-intensity
binary p-Stat5 signal is sufficient to support the essential
erythropoietic Stat5 functions required for life. We examined this
further by measuring Epo-mediated anti-apoptotic signaling in
Stat52/2 and EpoR-HM fetal liver erythroblasts. Anti-apoptosis is
a key function of Epo-activated Stat5 in both basal and stress
erythropoiesis, and is mediated by its transcriptional activation of
the anti-apoptotic protein bcl-xL and other targets [5–7,34,35].
We incubated fetal liver cells freshly isolated from EpoR-HM,
Stat52/2 and strain- matched wild-type control embryos in the
absence of Epo for 90 min. We then labeled the cells with Annexin
V, to detect cells undergoing apoptosis (Figure 6A,B). As reported
previously [6,34], a large fraction (40%) of Stat52/2 S1 cells, but
only 1%–2% of wild-type controls, were Annexin V positive,
confirming the essential role for Stat5 in erythroblast survival
(Figure 6A). By contrast, there was little apoptosis in the EpoR-
HM fetal liver (Figure 6B, representative example in upper panel,
summary of embryo litters in lower panel). Therefore, the low-
intensity, binary Stat5 signal generated in EpoR-HM erythroblasts
is sufficient for mediating Stat5’s anti-apoptotic functions.
EpoR-HM Adult Mice Fail to Upregulate Erythroblast
CD71, a Target of EpoR Stress Signaling
Although adult EpoR-HM mice are viable, they are neverthe-
less mildly anemic, and are deficient in their response to
erythropoietic stress [3,36]. Given our finding that these mice
retain the binary but lack the graded high-intensity Stat5 signaling
mode, we asked whether the latter is specifically required during
stress. The transferrin receptor, CD71, was recently identified as a
Stat5 transcriptional target, and Stat52/2 fetal liver erythroblasts
were found to express 50% lower levels of cell-surface CD71
(Figure 6C; [12,34]). Here we found that EpoR-HM fetal liver
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Figure 5. High exogenous Stat5 levels rescue high-intensity graded p-Stat5 signaling in wild-type and EpoR-HM S3 cells. (A) The p-
Stat5 response to Epo in S3 cells expressing exogenous FLAG-Stat5. Wild-type fetal liver cells were electroporated with either FLAG-tagged Stat5a
( = FLAG-Stat5, C-terminal tag, top panels), FLAG-tagged STAT5Y694F (middle panels), or ‘‘empty vector’’ (pcDNA3, lower panels). Following overnight
incubation in Epo (0.2 U/ml), cells were deprived of Epo for 3 h, and then either left unstimulated (left panels) or were stimulated with Epo for 30 min
(response to Epo=9 U/ml is shown; response to Epo concentrations 0.04 to 9 U/ml are shown in panels B, C). Double-headed arrows indicate
persisting p-Stat5 following a 3h Epo deprivation, seen only in cells expressing high levels of FLAG-Stat5. (B) Analysis strategy for the experiment
described in panel A. Dot plots of the p-Stat5 response versus FLAG-Stat5 levels are shown for three of the nine Epo concentrations examined (left
panels; Epo= 0, 0.33, or 9 U/ml) in EpoR-HM S3 erythroblasts. Each dot plot was subdivided into narrow vertical gates, each containing cells of similar
FLAG-Stat5 levels. Three of these gates, numbered 10 to 12, are highlighted in red, green, and blue, respectively. p-Stat5 responses to the three Epo
concentrations in a given gate (left panels) were overlayed in a single histogram (right panels). For example, responses of cells in gate 10 (red) in each
of the three left panels are all overlayed in the top right panel (framed red). (C) The ‘‘total p-Stat5’’ response to each of nine Epo concentrations for
each vertical gate in panel B, fitted with a Hill curve. Analysis is shown for both wild-type (WT) S3 cells and for EpoR-HM S3 cells (HM). Gate numbers
and Hill coefficients are indicated next to each curve. Data points are ‘‘total p-Stat5’’ (MFI6sem) for cells in a given gate. Each of the ‘‘total p-Stat5’’
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erythroblasts had a milder, though statistically significant, 15% loss
of CD71 expression (Figure 6D; p,0.002, unpaired t test),
potentially the result of their Stat5 signaling deficit. Although
CD71 is highly expressed on fetal and adult erythroid progenitors
during basal erythropoiesis, we found that there is a substantial,
further increase in its cell-surface expression during the stress
response (Figure 7A). Thus, a single subcutaneous Epo injection,
which generates stress levels of Epo in blood for ,24 h, caused a
3-fold increase in CD71 on the surface of splenic EryA
erythroblasts (CD71highTer119highFSChigh [21]) (Figure 7A, left
panel). Further, CD71 increased nearly 2-fold in the same cells in
mice placed in a reduced oxygen environment (11% oxygen,
Figure 7A, right panel); plasma Epo in these mice rises ,3-fold in
the initial 3 days following the onset of hypoxia. An in vivo Epo
dose/CD71 response analysis showed a graded increase in cell
surface CD71 in response to increasing Epo, with half the maximal
increase seen in mice injected with 3 U of Epo/25 g body weight
(Figure 7B), and a Hill coefficient of 1.5. These findings establish
CD71 as a target of erythropoietic stress whose level is modulated
with the degree of stress.
Given the mild but significant deficit of CD71 expression in EpoR-
HM fetal liver erythroblasts (Figure 6D), we examined expression of
erythroblast CD71 during the response of EpoR-HM adult mice to
stress (Figure 7C,D). We found that, unlike wild-type mice, EpoR-
HM mice completely failed to upregulate CD71 when injected with
high Epo (100 U/25 g mouse; Figure 7C,D). This failure may
account in part for the failure of EpoR-HM mice to accelerate
erythropoiesis and increase their hematocrit (Figure 7E) [3].
Exogenous Stat5 Rescues Stress-Induced CD71 Up-
Regulation in EpoR-HM Erythroblasts
Since high exogenous Stat5 restored the high-intensity graded
Stat5 signaling missing in EpoR-HM erythroblasts (Figure 5C), we
asked whether it may also restore high CD71 expression. We
measured CD71 expression in EpoR-HM and wild-type fetal liver
cells that were electroporated with FLAG-Stat5 in the experiment
illustrated in Figure 5A–D, following overnight culture in stress
Epo levels (0.2 U/ml, Figure 7F). We found that cells with
increasing FLAG-Stat5 protein showed a corresponding, gradual
increase in cell-surface CD71, in both wild-type and EpoR-HM
cells (Figure 7F). These findings strongly suggest that the graded,
stress-dependent CD71 up-regulation is a function specifically
mediated by the high-intensity graded Stat5 signal during the
erythropoietic response to stress.
Discussion
EpoR-activated Stat5 signaling in erythroid progenitors begins
with the transition from S0 to S1 (Figure S1A), a transition that
marks a developmental switch comprising transcriptional and
epigenetic erythroid commitment events including the onset of
dependence on EpoR signaling [18,19]. We identified two
modalities of p-Stat5 signaling in erythropoietic tissue, graded
and binary, each with distinct biological functions, which together
increase the information content of the Stat5 signal and allow
differential regulation of basal and stress erythropoiesis. In early
erythroblasts, a graded increase in Epo concentration generates a
graded p-Stat5 signal that reaches high intensities in response to
stress levels of Epo. The maximal p-Stat5 signal intensity declines,
however, with erythroblast maturation, to a 4-fold lower level in
more mature, S3 erythroblasts. The low-intensity p-Stat5 signal in
S3 erythroblasts has a steep response to increasing Epo
concentrations, characterized by Hill coefficients in the range of
three to four, which is similar to or steeper than the cooperative
binding of oxygen to hemoglobin [25]. This steepness converts a
graded Epo input into a binary, ‘‘on’’ or ‘‘off’’ response.
The gradual loss of high-intensity p-Stat5 signaling with
erythroid maturation is due in part to increasing expression of
SOCS3 (Figure S6) and to declining Stat5 protein (Figure 4). The
role played by Stat5 was first indicated by the strong correlation
between Stat5 protein levels and the maximal p-Stat5 signal
intensity, across all erythroblast differentiation subsets (Figure 4F).
We used exogenous Stat5 to confirm a causal role for Stat5 protein
levels in determining Stat5 signaling modality. Thus, we were able
to endow mature erythroblasts expressing high levels of exogenous
Stat5 with high-intensity graded signaling, and showed that
maximal p-Stat5 signal intensity was proportional to exogenous
Stat5 protein levels (Figure 5D).
Distinct Biological Functions for the Binary and Graded
Stat5 Signaling Modalities
The biological functions of the two Stat5 signaling modalities
are exemplified by the EpoR-HM and Stat52/2 mouse models.
EpoR-HM erythroblasts signal exclusively via the binary low-
intensity signal. Unlike Stat52/2 mice, which die of fatal perinatal
anemia due to erythroblast apoptosis, EpoR-HM mice are viable
with near-normal basal erythropoiesis and normal erythroblast
survival (Figure 6B). The binary low-intensity pStat5 signal
conveys binary, life or death decisions that rescue sufficient
numbers of erythroblasts from apoptosis to make developmental
and basal erythropoiesis possible.
By contrast, the EpoR-HM mice lack an efficient stress response
(Figure 7E, [3]). We found that up-regulation of CD71 on the
surface of erythroid precursors is a stress-specific graded response
that depends on high Epo levels in vivo (Figure 7A.B). It requires
the graded, high-intensity p-Stat5 signal that is elicited by stress
levels of Epo and that is missing in EpoR-HM mice. This is
evident from the finding that EpoR-HM erythroblasts fail to up-
regulate CD71 when subjected to high Epo and from rescue of the
CD71 response in EpoR-HM erythroblasts transduced with
exogenous Stat5, which restores the high-intensity p-Stat5 signal
to these cells (Figure 7F, Figure 5C). Exogenous Stat5 similarly
endowed mature wild-type erythroblasts with both high-intensity
graded Stat5 signaling and with the ability to induce stress levels of
CD71 (Figure 7F, Figure 5C). These findings strongly suggest that
the ability of an erythroblast to generate the CD71 stress response
is determined by its ability to generate the high-intensity p-Stat5
signal, and not by other aspects of erythroblast maturation.
The Transferrin Receptor Is a Novel Target of
Erythropoietic Stress
Although the transferrin receptor (CD71) is ubiquitous in
dividing cells, it is expressed at uniquely high levels in erythroid
MFI measurements was corrected by subtracting background fluorescence, given by the ‘‘total p-Stat5’’ MFI of cells expressing FLAG-Stat5Y694F in
the same gate (see panel A). Gates 6 and 7 for wild-type cells and gates 9 and 10 for HM cells are re-plotted with an expanded y-axis. (D) Linear
correlation between FLAG-Stat5 levels in each vertical gate, and the corresponding maximal p-Stat5 signal intensity (p-Stat5max), in wild-type cells
(top panel, R2 = 0.96) and EpoR-HM S3 cells (lower panel, R2 = 0.998); analysis is of data shown in panel C. p-Stat5max is the maximal p-Stat5 response
to Epo, defined by the Hill equation in Figure S3 and obtained by fitting Hill curves to the data in (C).
doi:10.1371/journal.pbio.1001383.g005
Stat5 Signals through Binary and Graded Modalities
PLOS Biology | www.plosbiology.org 12 August 2012 | Volume 10 | Issue 8 | e1001383
progenitors, where it provides the high iron requirement for
hemoglobin synthesis. Genetic mutations that decrease either
CD71 or plasma iron compromise erythropoiesis, resulting in
anemia and a loss of the stress response [37,38]. Recently, Stat5
was shown to be required for optimal erythroblast CD71
expression in the fetus [12,34].
Here we found that, during stress, CD71 in early erythroblasts
increases beyond its already high level in basal erythropoiesis
(Figure 7A–B). This increase is a Stat5-dependent function that
specifically requires the high-intensity Stat5 signaling mode
(Figure 7C–F). Though not reported previously, the increase in
cell-surface transferrin receptor during stress is consistent with the
higher requirement for iron during stress erythropoiesis [37,38]. It
is also consistent with the increase in plasma soluble transferrin
receptor, a known clinical indicator of increased erythropoietic
rate [39]. The failure of EpoR-HM mice to up-regulate CD71
may therefore account for their deficient stress response. It is likely,
however, that additional functions regulated by the high-intensity
p-Stat5 signal also contribute, including a stress-dependent
increase in the level of the anti-apoptotic bcl-xL protein [5].
Coexisting Graded and Binary Modalities Permit High
Fidelity Signaling over a Wide Epo Range
Binary and graded signaling modes have fundamentally
different functional consequences. The steepness of the binary
dose/response curve has the advantage of filtering out noise and
generating a clear signal that is easily distinguishable from
background. This mode of signaling is therefore ideal at the low
end of the Epo concentration range, where Epo stimuli, though
low, are nevertheless essential for basal erythropoiesis and must be
clearly distinguished from noise. A key disadvantage of binary
signaling, however, is its inability to encode incremental changes
Figure 6. Stat5 functions in EpoR-HM and Stat52/2 fetal liver. (A, B) Increased erythroblast apoptosis in Stat52/2 but not in EpoR-HM fetal
liver. Freshly harvested fetal livers from E13.5 Stat52/2 or EpoR-HM embryos and from littermate or strain-matched controls were incubated in the
absence of Epo for 90 min. Cells were then labeled with 7-AAD to exclude dead cells, and with Annexin V, CD71, and Ter119 to assess apoptosis.
Representative histograms are shown for S1 cells in Stat52/2 fetal liver and in matched control (A), and for S1 cells of EpoR-HM fetal liver and
matched control (B). Summary of Annexin-V+ cells in three independent experiments is shown in corresponding lower panels; each data point
corresponds to an individual embryo, the black line is the mean for all embryos of a given genotype. Number of embryos analyzed: EpoR-HM=15,
strain and age matched controls = 20; Stat52/2= 5, littermate controls = 5. No statistically significant difference was detected between EpoR-HM and
control embryos; the difference between Stat52/2 and control embryos is significant (p=0.0007, two-tailed t test, unequal variance). (C, D) Cell-
surface CD71 in Stat52/2 and EpoR-HM fetal liver. E13.5 or E14.5 fetal liver from Stat52/2, EpoR-HM, or matched control embryos were labeled with
CD71 and Ter119. Non-viable cells were excluded with 7-AAD. Top panels show representative flow-cytometric CD71/Ter119 profiles of viable, non-
fixed fetal liver cells. Lower panels show data for all Stat52/2 embryos (n= 7, each data point is an individual embryo), Stat5+/2 (n= 11), and wild-type
littermates (n= 8), and for EpoR-HM (n= 19) and strain-matched controls (n= 14). Difference between HM and matched control is significant
(p,0.002, unpaired t test); Differences between Stat5+/2, Stat52/2, and wild-type mice are all significant (p,0.0001, one-way ANOVA).
doi:10.1371/journal.pbio.1001383.g006
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Figure 7. CD71 up-regulation is an EpoR-activated stress response that requires the high-intensity, graded p-Stat5 signal. (A)
Erythropoietic stress causes up-regulation of cell-surface CD71 on spleen EryA erythroblasts (CD71highTer119highFSChigh). At t = 0, Balb/C mice were
injected with Epo subcutaneously (300 U/ml, left panel) or placed in an hypoxia chamber (11% oxygen, right panel). Spleen was harvested at the
indicated time points. Cell-surface CD71 was measured using flow-cytometry in EryA. Data points are MFI 6 sem for three to six mice per time point,
expressed as relative fluorescence units. (B) A dose/response curve in vivo of CD71 up-regulation in response to stress levels of Epo. Balb/C mice were
injected with a single subcutaneous Epo dose as indicated. Spleen was harvested at t = 24 h post-injection, and EryA CD71 was measured by flow
cytometry. Data points are MFI 6 sem of three to eight mice per Epo dose, pooled from two independent experiments, and expressed relative to
CD71 levels at t = 0. Bone-marrow EryA CD71 increased similarly. (C–E) EpoR-HM mice fail to up-regulate CD71 and to increase erythropoietic rate in
response to stress levels of Epo. Adult EpoR-HM mice or strain-matched wild-type mice were injected with a single Epo dose (100 U/25 g mouse) or
Stat5 Signals through Binary and Graded Modalities
PLOS Biology | www.plosbiology.org 14 August 2012 | Volume 10 | Issue 8 | e1001383
in stimulus. This would exclude it as a useful signaling modality in
erythropoietic stress, where Epo concentration determines the
precise level of erythropoietic acceleration that is required to
compensate for hypoxia.
Stat5 bridges this conundrum by combining the binary and
graded signaling modalities in a manner analogous to a dimmer
switch (Figure 8A), allowing signaling fidelity over a wide Epo
concentration range. Low stimuli activate the binary component of
the dimmer switch from ‘‘off’’ (open on/off switch, Figure 8A) to
‘‘on’’ (closed on/off switch), which closes the electric circuit and
switches the light on. A further turning of the power dial
incrementally reduces the circuit’s resistance, resulting in an
incremental, graded increase in light intensity. Similarly, low Epo
stimuli result in a binary activation of p-Stat5. In S1 cells, this
binary activation is superseded at higher Epo stimuli with a
further, graded increase in the p-Stat5 signal intensity (Figure 8B).
Of note, although S3 cells are individually limited to a low-
intensity binary response, increasing Epo results in an increasing
number of signaling S3 cells, due to their varying activation
thresholds (Figure 8B).
At the level of gene transcription, p-Stat5 signal intensity, rather
than the steepness of the dose/response curve, is likely to
determine which subset of gene targets will be activated. As
example, it is likely that activation of lower affinity Stat5 binding
sites will require higher p-Stat5 concentration, manifesting as
higher signal intensities. Further, the p-Stat5 signal intensity may
affect the likelihood of formation of Stat5 tetramers, which appear
to bind to a functionally distinct subset of Stat5 targets [40,41].
While a steep dose/response curve is unlikely to determine
which Stat5 targets are activated, its role is to ensure that the low-
intensity p-Stat5 signal is generated only in response to a
biologically appropriate stimulus. A key challenge of low-intensity
signals is their inherently low signal-to-noise ratio. The steep dose/
response curve of binary signaling provides a threshold for
activation that filters out random noise and ensures that the low-
intensity signal is decisive.
Networks containing similar signaling components and similar
topologies may vary in their output, generating either binary
(digital) or graded (analog) responses, depending on the value of
key parameters [42–44]. Thus, apparently homologous MAPK
modules generate a switch-like response in Xenopus oocytes, but a
graded response in the yeast mating pheromone pathway [43].
Further, isogenic yeast cells use a similar complement of
transcription factors to generate either binary or graded
transcriptional responses from the Gal1 promoter [42]. The
mechanism(s) that determine whether a response is binary or
graded in these examples is not fully understood [43]. By contrast,
Ozbudak et al. showed both theoretically and experimentally that
it is possible to interconvert binary and graded responses of the E.
coli lac operon simply by titrating the Lac repressor LacI [44].
Recent reports suggest that binary and graded signaling modalities
may coexist in cells [16,45]. Thus, Ras signaling in T lymphocytes
is of a low-intensity, analog form, but can assume a high-intensity,
digital form when an SOS positive feedback loop is activated.
Here we suggest that low concentration of the Stat5 protein
results in a binary response, while a high concentration generates a
graded response. This model is consistent with the following data:
(i) steeper dose/response curves in the Stat5+/2 S3, which contain
less Stat5, compared with wild-type S3 (Figure 4B); (ii) steeper
dose/response curves in the more mature subsets of S3 (Figure 3G),
consistent with decreasing levels of Stat5 protein with maturation
(Figure 4D–E); and (iii) gradual conversion from binary to graded
responses in cells expressing increasing levels of transduced FLAG-
Stat5 (Figure 5C).
The binary response of EpoR-HM may be explained within the
same framework. Presumably, docking of Stat5 on EpoR
phosphotyrosines increases Stat5 concentration in the immediate
vicinity of the EpoR/Jak2 complex. The absence of EpoR
phosphotyrosines in EpoR-HM might be expected to result in
lower Stat5 concentration within the locality of EpoR/Jak2 and be
functionally equivalent to low cellular Stat5. Support for this
comes from the fact that we can rescue graded signaling in EpoR-
HM by transducing these cells with high FLAG-Stat5 (Figure 5C,
lower panels).
It is unclear at this point how Stat5 concentration determines
the steepness of the dose/response curve, a question that will form
the focus of future work.
EpoR Does not Limit Stat5 Signaling Intensity in
Erythroblasts
Reduced levels of EpoR in EpoR+/2 erythroblasts do not
prevent the generation of a maximal p-Stat5 signal (Figure 4C,
Figure S8). Further, the low-intensity p-Stat5 signal can be
converted into a high-intensity signal by exogenous high
expression of FLAG-Stat5, consistent with EpoR expression in
these cells not being limiting to the p-Stat5 signal (Figure 5C–D).
Estimates of the EpoR cell-surface occupancy required to
generate the p-Stat5 response are consistent with the conclusion
that cell surface EpoR is not limiting for this response. Using a
value of 130,000 U of Epo per milligram [46], a dissociation
constant (KD) for Epo of 240 pmol/L [1] and Epo’s molecular
weight (34,000 Daltons), 50% occupancy will be seen at Epo
concentrations of 1 U/ml. This is a much higher concentration
than the apparent Km for generating the half-maximal p-Stat5
response, which we found to be between 0.06 and 0.15 U/ml
(Figures S3B, S7A, S7C). Assuming a hyperbolic binding curve for
Epo, basal Epo levels (0.010–0.020 U/ml) would occupy only 1%–
2% of the cell surface EpoR, and an Epo concentration of 0.1 U/
ml, generating half the maximal p-Stat5 response, would increase
EpoR occupancy to 10%. At 35% occupancy, the p-Stat5
response is expected to be near-maximal in all erythroblast
subsets. The very highest Epo levels, found for example in aplastic
anemia, of 10 U/ml, result in 90% EpoR occupancy. This analysis
with saline control. Cell surface CD71 (C, D) and hematocrit (E) were measured at the indicated time points. (C) Representative CD71 flow-cytometry
histograms of spleen EryA, in either wild-type (WT) or EpoR-HM (HM) mice, injected with either saline or Epo, at 24 h post-injection. Two mice are
shown for each condition. (D) Summary of data measured as in (C), for HM and WT mice injected with either Epo or saline, at 18 and 24 h post-
injection. Each datapoint represents CD71 levels (MFI) in spleen EryA from a single mouse. Two to five mice are shown per time point/genotype
combination. (E) Hematocrit response to Epo injection. The hematocrit increases in the wild-type, but not in the EpoR-HM mouse. (F) Rescue of stress-
induced CD71 up-regulation in EpoR-HM fetal liver cells after rescue of high-intensity graded p-Stat5 signaling by transduction with high levels of
FLAG-Stat5. EpoR-HM or wild-type fetal liver erythroblasts were transduced with either FLAG-Stat5 or FLAG-Stat5Y694, as described in Figure 5A. Cells
were incubated overnight in the presence of stress-levels of Epo (0.2 U/ml; this is 6- to 10-fold the Epo basal levels), and were then labeled and
analyzed for CD71, Ter119, and FLAG expression by flow-cytometry. Datapoints are CD71 (MFI 6 sem) for each FLAG vertical gate, as illustrated in
Figure 5B, following correction for background fluorescence by subtracting the corresponding fluorescence for each FLAG gate of samples
transduced with FLAG-Stat5Y694F.
doi:10.1371/journal.pbio.1001383.g007
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suggests that cell-surface EpoR has vast reserves with respect to the
generation of the p-Stat5 signal.
The Role of Stat5 Dosage in Developmental and Disease-
Related Stat5 Signaling
We found that the maximal p-Stat5 signal intensity generated
by a maximal Epo stimulus is largely determined by Stat5 protein
levels (Figures 4F, 5C–D), though it is also affected by high SOCS3
expression in mature erythroblasts (Figure S6).
Michaelis-Menten enzyme kinetics assumes that the substrate is
present in excess, and is therefore not applicable to Stat5 signaling
in erythroblasts, where the substrate is limiting ([31,32]; see Text
S1). This non-Michaelian behavior may explain recent reports
linking higher Stat5 gene dosage or expression to leukemogenesis
[47,48]. Thus, based on our findings, we suggest that the higher
Stat5 protein found in leukemia cells may be causing a higher p-
Stat5 signal, possibly activating gene targets that contribute to
leukemogenesis. These considerations underscore the importance
of identifying regulators of Stat5 expression both during normal
erythroid differentiation and in leukemia.
Our findings raise the possibility that there may be signaling
pathways other than EpoR-Jak2-Stat5 in which the second
messenger molecule, and not its upstream receptor, is limiting to
the signal response. This non-Michaelian behavior has implications
when such pathways are activated pathologically. To date,
inhibition of abnormal signaling in tumor cells has largely focused
on membrane or nuclear receptors and on other early or first steps
of signaling cascades. Examples include the inhibition of the
epidermal growth-factor (EGF) receptors, over-expressed in many
solid tumors, and inhibition of Jak2 or Bcr-Abl in myeloproliferative
Figure 8. Dimmer-switch model of Stat5 signaling. (A) The operation of a dimmer switch combines binary and graded components. The
closing of an ‘‘on/off’’ switch closes an electric circuit, allowing current to flow and switches on a dim light. A gradual further turning of the power-
switch dial permits a gradual decrease of the circuit’s resistance, with a consequent graded increase in the electric current and light intensity. (B) The
p-Stat5 signal is turned ‘‘on’’ through a binary action, to produce a low-intensity but decisive signal in S3 erythroblasts or in EpoR-HM erythroblasts. In
S1 early erythroblasts, this signal can increase further with a gradual further increase in Epo concentration. No further increase takes place in mature
S3 erythroblasts, though the number of signaling erythroblasts increases with increasing Epo.
doi:10.1371/journal.pbio.1001383.g008
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disease and leukemia [49–52]. Our work suggests an alternative
therapeutic paradigm, in which targeting second messengers that
are limiting to signal transduction may be an effective therapeutic
strategy. In the case of Stat5, targeting its high-intensity signaling
may inhibit its function in myeloproliferative disease without
affecting the binary low-intensity p-Stat5 response in normal cells.
Materials and Methods
Fetal Liver Cell Preparation
Fetal livers were isolated at E12.5–E14.5, dissociated mechan-
ically, and deprived of Epo for 90 min in the presence of 20%
serum prior to Epo stimulation. Electroporations were performed
using Amaxa Biosystem Nucleofector on fresh fetal liver. Cells
were incubated for 18 h in Epo (0.2 U/mL), Stem Cell Factor
(100 ng/mL), and Interleukin-3 (10 ng/mL) and washed 3 times
and incubated in 20% serum for 3 h prior to Epo stimulation.
Flow Cytometry
Epo-stimulated cells were harvested in phosphowash (PBS,
1 mM sodium orthovanadate, 1 mM b-glycerol phosphate, 1 mg/
mL microcystin), fixed in 1.6% paraformaldehyde, permeabilized
in 80% acetone, and stored at 280uC. Thawed cells were stained
in PBS/3% milk with AF647-conjugated anti-phospho Stat5
(612599, BD Biosciences), for Ter119 and CD71 as described
[21], and where indicated, for Stat5 (ab 7969, Abcam followed by
anti-rabbit-APC, Jackson ImmunoResearch Laboratories), FLAG
(F4049, Sigma Aldrich), and Myc (2272, Cell Signaling Technol-
ogy). In all electroporation experiments, cells were stained with
LIVE/DEAD Fixable Blue Dead Cell Stain Kit for UV excitation
(L-23105, Invitrogen), prior to fixation and permeabilization in
order to exclude dead cells from analysis. l-phosphatase treatment
was for 15 min at 37uC on fixed and permeabilized cells (1,000
units, New England Biolabs).
Apoptosis assays were done on fresh fetal livers that were
deprived of Epo for 90 min and then stained for CD71, Ter119,
and Annexin V according to the manufacturer’s instructions (BD
Biosciences). Spleen and bone marrow cells isolated from adult
mice were immediately stained with CD71 and Ter119 as
described [21]. Cells were analyzed on an LSRII cytometer (BD
Biosciences). Data were analyzed with FlowJo software (Tree Star,
Stanford University, Stanford, CA).
For mouse strains, DNA constructs, quantitative RT-PCR, and
si-RNA, see Text S2.
Supporting Information
Figure S1 The p-Stat5 response in fetal liver. (A) The p-Stat5
response of fetal liver subsets S0 to S3 to Epo (2 U/ml, 15 min).
Freshly isolated fetal liver cells were deprived of Epo for 90 min and
were then stimulated. Cells were labeled for CD71, Ter119, and p-
Stat5. (B) Time-course of the p-Stat5 response to Epo (2 U/ml for
up to 6 h). Each of the three measures used to assess the p-Stat5
response (see Figure 1C, main text) is plotted versus time.
Representative of five similar experiments. (C) Representative
responses of S0 cells to stimulation with a range of Epo
concentrations for 15 min. Flow-cytometry histogram overlay is
shown. Even at the highest Epo concentrations, only 20% to 30% of
S0 cells are responsive to Epo. For responding cells, the p-Stat5 MFI
increases with Epo concentration, in the manner seen for S1 cells.
(TIF)
Figure S2 The p-Stat5 response in adult spleen and bone marrow
in vivo. (A–F) Time course of the p-Stat5 response to Epo stimulation
in vivo, in adult mouse bone marrow and spleen. Mice were injected
with Epo (100 U/25 g mouse subcutaneously). Bone marrow and
spleen were harvested at the indicated time points for up to 16 h
following injection, and cells were immediately fixed, permeabilized,
and labeled for CD71, Ter119, and p-Stat5. Erythroid subsets in
adult mouse bone marrow or spleen may be defined by flow
cytometry using cell surface Ter119 and CD71 [21]. Subsets
ProEREryAREryBREryC contain erythroid precursors of increas-
ing maturity. The maturation stage of ProE resembles that of S2 in
fetal liver and the maturation stage of EryA resembles that of S3. (A–
C) Bone marrow subsets. (D–F) Spleen subsets. (A, D) The ‘‘total p-
Stat5’’ response. (B, E) p-Stat5+ cells. (C, F) p-Stat5 in p-Stat5+ cells
(solid lines). For comparison, the dashed lines show the ‘‘total p-Stat5’’
response data from (A, D), respectively. Data were pooled from four
independent experiments. Each time point is the mean6 sem of data
from two to four mice. MFI data are normalized as follows:
background MFI in the absence of Epo is subtracted, and the
remainderMFI is expressed as a ratio toMFI of p-Stat5+ cells in bone
marrow EryA at time=1 h for each experiment.
(TIF)
Figure S3 Binary p-Sta5 signaling in EpoR-HM erythroblasts. (A)
Representative plots of ‘‘total p-Stat5 versus Epo concentration’’ for
subsets S1 to S3 in wild-type (left panel) and EpoR-HM (right panel)
fetal liver. The same experiment as in Figure 3C, main text. (B)
Three independent experiments assessing p-Stat5 signaling in EpoR-
HMmice. Values for p-Stat5max and apparent Km were obtained by
fitting Hill curves to plots of ‘‘total p-Stat5 MFI versus Epo
concentration’’ of the type illustrated in (A). The Hill equation was





, where S=Epo concen-
tration in U/ml, and p-Stat5 is the total p-Stat5 fluorescence; best fit
was obtained by varying n ( =Hill coefficient, ‘‘nH’’ in the text), Km
( = the apparent Km), and p-Stat5max ( = the maximal p-Stat5
response to high Epo), using the solver function of Microsoft Excel.
R2 is Pearson’s product moment correlation coefficient, correlating
experimental data with values predicted by the Hill equation for the
corresponding Epo concentrations. The Hill coefficients and R2
values for this analysis are shown in Figure 3E, main text. The Km
and p-Stat5max were all significantly different in wild-type and
EpoR-HM mice (paired t test, p=0.003 and 0.023, respectively).
(TIF)
Figure S4 Comparison of dose/response curves in E12.5 and
E14.5 embryos. E12.5 and E14.5 fetal livers were stimulated with
Epo and analyzed by flow cytometry in the same experiment. The
data for the E14.5 fetal liver are also shown in Figure 3F–G. (A)
CD71/Ter119 profiles of E12.5 and E14.5 fetal livers (left panels).
The S3 subsets were divided into serial FSC gates, each
corresponding to 300 channels (middle panels). Right panels show
an overlay of Ter119 expression in FSC gates #3 and #6 for each
of the embryos. (B) Epo dose/p-Stat5 response curves for the S3
FSC gates in the E12.5 and E14.5 embryos. Gate number and
corresponding Hill coefficient are shown for each curve. (C)
Overlay of the indicated dose/response curves.
(TIF)
Figure S5 Stat5 signaling in Shp12/2 (C57BL/6J-Ptpn6me/J)
fetal liver. (A) Quantitative real-time PCR for Shp1 in sorted S0–
S3 subsets from wild-type embryos (E12.5–E13.5). The left panel
shows Shp1 mRNA relative to b actin (mean 6 SE), calculated
from three independent experiments. The right panel shows the
DCt 6 SE for each individual experiment. (B) Epo dose/p-Stat5
response analysis in Shp12/2 fetal liver fitted with Hill curves.
Data (mean) from two independent experiments, each with one
embryo of each genotype. Normalization as in Figure 1E. (C)
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Time course of p-Stat5 response to Epo stimulation with 0.2 U/
ml, in Shp12/2 embryos (n=5) and in matched controls (n=3).
Data points are measurements in individual embryos.
(TIF)
Figure S6 SOCS3 regulation of Stat5 signaling. (A) Quantitative
real-time PCR for SOCS3 in sorted S0–S3 subsets from wild-type
embryos (E13–E14.5). The left panel shows SOCS3 mRNA relative
to b actin (mean 6 SE), calculated from three independent
experiments. The right panel shows the DCt 6 SE for each
individual experiment. (B, C) Fetal liver cells were electroporated
with SOCS3 siRNA or with ‘‘scrambled’’ control siRNA. Four
hours later cells were stimulated with Epo. Both SOCS3 mRNA (B)
and the p-Stat5 response (C) were measured at the indicated times.
(TIF)
Figure S7 p-Stat5 signaling in Stat5+/2 and EpoR+/2 erythro-
blasts. (A) Epo Dose/p-Stat5 response analysis of Stat5+/2 fetal liver.
Values for the Hill coefficients, p-Stat5max, and apparent Km were
obtained by fitting Hill curves (see legend to Figure S3B) to the ‘‘total
p-Stat5 MFI versus Epo concentration’’ data (main text, Figure 4B).
Note a substantially lower p-Stat5max in Stat5
+/2 embryos. A total of
seven Stat5+/2 and six control embryos were individually analyzed.
R2 is Pearson’s product moment correlation coefficient. (B) EpoR
mRNA in wild-type (WT, circles) and EpoR+/2 (squares) fetal liver,
measured using quantitative RT-PCR at E13.5. Data points
represent measurements in individual embryos, and are expressed
relative to b actin mRNA. Mean values for each genotype are
denoted with a black line. (C) Epo Dose/p-Stat5 response analysis of
EpoR+/2 fetal liver. Analysis as for Stat5+/2 embryos in panel A, of
data presented in Figure 4C. Note doubling of the apparent Km in
EpoR+/2 embryos (resulting in a shift of the curve to the right). A
total of four EpoR+/2 and three control embryos were analyzed
independently. (D) Measurements of Stat5 protein levels in fetal liver
subsets using flow-cytometry. Fixed and permeabilized fetal liver
cells were labeled with antibodies against Ter119 and CD71, and in
addition, with a rabbit polyclonal antibody, which recognizes Stat5
regardless of its state of activation (ab 7969, Abcam) and a secondary
anti-rabbit IgG antibody conjugated to APC. Flow cytometry
histograms reflecting total Stat5 protein expression (as APC
fluorescence) are shown for two Stat52/2 embryos (these provide
the non-specific background fluorescence), and for one wild-type and
one Stat5+/2 embryo. Stat5 expression in Figure 4D–F was
determined as Stat5 MFI, with background fluorescence subtracted,
and expressed as a ratio to the average Stat5 MFI of S1 cells.
(TIF)
Figure S8 EpoR expression is not limiting to the maximal p-Stat5
signal. Ter119-negative cells were sorted from E13.5 fetal livers using
magnetic beads. The cells from each fetal liver were divided into two
aliquots, one of which was stimulated with Epo. The entire lysate
from each aliquot was resolved using SDS-PAGE and analyzed by
Western blotting. Two independent litters were processed. (A)
Western blot analysis of embryos from a single litter. The membrane
was stripped and re-probed sequentially with antibodies to p-EpoR,
p-Stat5, and the transferrin receptor. The transferrin receptor signal
indicates the presence of S1 erythroblasts. Chemiluminescence was
quantitated using Bio-Rad Molecular Imager Chemi Doc XRS+ and
Image Lab Software Version 3.0.1, Bio-Rad Laboratories. The
pseudo-color is a software tool indicating increasing signal intensity, in
the order pink (= background), blue, green, and red (=maximal). All
signals were within the linear range as confirmed by sequential
automated timed exposures. (B) The p-EpoR/p-Stat5 ratio for wild-
type and EpoR+/2 embryos. Each data point is derived from a single
fetal liver. Three wild-type and five EpoR+/2 fetal livers were pooled
from two litters. Ratios were 1.760.02 for wild-type, 1.160.08 for
EpoR+/2, p=0.002, two-tailed t test with unequal variance.
(TIF)
Figure S9 Measurement of exogenous Stat5 protein in transfected
fetal liver cells. (A, B) Fetal liver cells were electroporated with FLAG-
tagged Stat5a (‘‘FLAG-Stat5’’) or with control ‘‘empty vector’’
(‘‘pcDNA3’’). Cells were incubated overnight in the presence of Epo
(0.2 U/ml), to allow expression of the transduced constructs.
Expression of exogenous FLAG-Stat5 protein and p-Stat5 signaling
were measured at 18 h. (A) Stat5 protein levels are assessed as in
Figure S7D. Top panel, Stat5 protein in freshly isolated S1 and S3
cells, prior to transfection with FLAG-Stat5. Middle panel, Stat5
protein in S3 cells transduced with either FLAG-Stat5 (red) or with
empty vector (pcDNA3, green). Stat5 protein in fresh S3 cells (black)
is shown for comparison. Lower panel, Stat5 protein in S3 cells
transduced with FLAG-Stat5 (red), compared with Stat5 protein
levels in fresh S1 cells (blue). (B) Measurement of FLAG fluorescence
is an accurate assessment of exogenous Stat5 protein levels. S3 cells
transfected with either FLAG-Stat5 (red) or empty vector (green),
labeled with both anti-FLAG antibody (x-axis) and an anti-Stat5
antibody (y-axis). A linear correlation is observed between FLAG and
Stat5 staining in FLAG-Stat5 transfected cells.
(TIF)
Text S1 Supplementary analysis: Cellular Stat5 is limiting
during Stat5 phosphorylation in erythroid cells.
(PDF)
Text S2 Supplementary materials and methods.
(PDF)
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